
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-09-02-2015
- Volume 11
- Issue 9
Spectrometers Comply with FDA Electronic Signature Regulation
Shimadzu Scientific Instruments reports its EDX-7000/8000 spectrometers are compliant with electronic signature regulations.
Shimadzu Scientific Instruments (SSI) has announced its EDX-7000/8000 energy dispersive x-ray fluorescence spectrometers are compliant with the 21 CFR Part 11 electronic signature regulation designated by FDA.
The compliancy confirms that the electronic records produced by the spectrometers are trustworthy and reliable for use in the pharmaceutical and food industries. It also confirms the reliability of other key instrument features needed for these industries, including security, user’s rights management, validation, and operation and audit trail output, the company reports in a press release.
The instrument features a secure user authentication and screen lock function that allows only authorized users access to the system. Login information is also recorded in a secure operational history log. The instrument’s audit trail log function allows users to output audit trail logs, including instrument setting change history and user operation history.
Source:
Articles in this issue
about 10 years ago
Technology Allows Automated Lab Reactor Controlabout 10 years ago
Flow Chemistry Systems Offer Optionsabout 10 years ago
Pressure Reactor for Small Batch Reaction Chemistryabout 10 years ago
Homogenizer Offers Continuous Operationabout 10 years ago
Mayne Pharma to Invest $65m in Manufacturing Expansionabout 10 years ago
Next Step for Elemental Impuritiesabout 10 years ago
WuXi PharmaTech Supplies Laboratory Testing Services to Lee's Pharmabout 10 years ago
Cytovance Biologics Acquired by Hepalinkabout 10 years ago
Industry Responds to FDA Metrics ProgramNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





